ReviewJCO precision oncology2022

Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.

Pashtoon M Kasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.